Skip to main content
. 2005 Aug 30;93(7):834–837. doi: 10.1038/sj.bjc.6602751

Table 2. RR of developing multiple myeloma by lag between sampling and diagnosis.

  MM on follow-up Healthy on follow-up RR 95% CI
Cases with lag >24 months:
 IFA lytic        
  No 267 1288 1  
  Yes 37 221 0.8 (0.5–1.2)
         
 IFA latent        
  No 302 1498 1  
  Yes 2 11 0.9 (0.1–4.2)
         
Cases with <median lag (121 months)
 IFA lytic        
  No 144 668 1  
  Yes 20 143 0.6 (0.4–1.1)
         
 IFA latent        
  No 163 798 1  
  Yes 1 13 0.4 (0.0–2.6)
         
Cases with at least median lag (121 months)
 IFA lytic        
  No 146 725 1  
  Yes 19 95 1.0 (0.5–1.7)
         
 IFA latent        
  No 164 817 1  
  Yes 1 3 1.7 (0.0–2.1)

RR=relative risk; MM=multiple myeloma; CI=confidence interval; IFA=immunofluorescence assay.

Method: exact conditional logistic regression, adjustment for freeze–thawing.